Predictions
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€9.20
20.11.20
20.11.20
€11.00
20.11.21
20.11.21
-27.72%
10.12.20
10.12.20
Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Vaalco Energy Inc.
Start price
Target price
Perf. (%)
€1.09
19.11.20
19.11.20
-
19.11.21
19.11.21
173.39%
20.11.21
20.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Probably not worthwhile Investment
ElringKlinger AG
Start price
Target price
Perf. (%)
€12.08
18.11.20
18.11.20
€14.00
12.75%
24.11.20
24.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Vaalco Energy Inc.
Start price
Target price
Perf. (%)
€1.27
18.11.20
18.11.20
€2.00
18.11.21
18.11.21
6.30%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Capable Management
Bad rating
Growths slower than the competition
MagForce AG
Start price
Target price
Perf. (%)
€3.01
18.11.20
18.11.20
€4.00
18.11.21
18.11.21
12.29%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Neptune Wellness Solutions Inc
Start price
Target price
Perf. (%)
€60.55
16.11.20
16.11.20
€105.00
16.11.21
16.11.21
-10.40%
28.11.20
28.11.20
Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Kintara Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.35
16.11.20
16.11.20
€1.00
16.11.21
16.11.21
-45.11%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.50
16.11.20
16.11.20
€13.00
16.11.21
16.11.21
-3.48%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.20
16.11.20
16.11.20
€15.00
16.11.21
16.11.21
2.27%
30.11.20
30.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€18.10
16.11.20
16.11.20
€20.00
16.11.21
16.11.21
16.02%
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
16.11.20
16.11.20
€7.00
16.11.21
16.11.21
-
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
CBAK Energy Technology Inc
Start price
Target price
Perf. (%)
€7.65
16.11.20
16.11.20
€2.00
16.11.21
16.11.21
-75.16%
17.11.21
17.11.21
Probably not worthwhile Investment
SPI Energy Co Ltd ADR
Start price
Target price
Perf. (%)
€6.95
16.11.20
16.11.20
€5.00
16.11.21
16.11.21
32.37%
20.11.20
20.11.20
Valuable balance sheet
Capable Management
Sustainability is not important
ROE lower than 10% per year
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€8.00
16.11.20
16.11.20
-
16.11.21
16.11.21
9.13%
24.01.21
24.01.21
Significant cyclical dependencies
Risky Investment
Below average Marketposition
Business model of the past or high risk
HighPoint Resources Corp.
Start price
Target price
Perf. (%)
€5.33
16.11.20
16.11.20
-
16.11.21
16.11.21
110.13%
20.11.20
20.11.20
Could be worthwhile Investment >10% per year
Capable Management
Little innovation
Sierra Metals Inc
Start price
Target price
Perf. (%)
€2.02
16.11.20
16.11.20
-
16.11.21
16.11.21
-7.92%
23.08.21
23.08.21
Could be very worthwhile Investment >20% year
Eldorado Gold Corp.
Start price
Target price
Perf. (%)
€11.41
16.11.20
16.11.20
-
16.11.21
16.11.21
-3.55%
10.12.20
10.12.20
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Mag Silver Corp.
Start price
Target price
Perf. (%)
€15.17
16.11.20
16.11.20
-
16.11.21
16.11.21
-19.78%
30.11.20
30.11.20
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Innate Pharma
Start price
Target price
Perf. (%)
€4.10
15.11.20
15.11.20
€5.50
15.11.21
15.11.21
7.86%
16.11.21
16.11.21
Could be worthwhile Investment >10% per year
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€5.99
14.11.20
14.11.20
-
14.11.21
14.11.21
35.51%
11.12.20
11.12.20
Probably not worthwhile Investment
Very high cyclical dependencies
Below average Marketposition
Higher risks for its business
Curevac N.V.
Start price
Target price
Perf. (%)
€65.01
14.11.20
14.11.20
-
6.54%
26.11.20
26.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation